To include your compound in the COVID-19 Resource Center, submit it here.

Erbitux cetuximab: Phase III data

In a Phase III trial (NCIC CTG CO.17) in 572 patients, Erbitux plus

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE